ESA Treatment Selection in MDS : vimarsana.com

Clinical insights on selecting appropriate erythropoiesis-stimulating agents in patients with myelodysplastic syndromes.

Related Keywords

, Evolving Treatment Landscape , Myelodysplastic Syndromes , Mds , Mds Treatment , Myelodysplastic Syndromes Treatment , Erythropoiesis , Esa , Darbepoetin , Erythropoiesis Stimulating Agent ,